Fennec Pharmaceuticals Inc
TSX:FRX
Intrinsic Value
The intrinsic value of one FRX stock under the Base Case scenario is 25.26 CAD. Compared to the current market price of 10.77 CAD, Fennec Pharmaceuticals Inc is Undervalued by 57%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Fennec Pharmaceuticals Inc
Fundamental Analysis

Revenue & Expenses Breakdown
Fennec Pharmaceuticals Inc
Balance Sheet Decomposition
Fennec Pharmaceuticals Inc
Current Assets | 44.1m |
Cash & Short-Term Investments | 26.6m |
Receivables | 12.9m |
Other Current Assets | 4.6m |
Non-Current Assets | 822k |
Other Non-Current Assets | 822k |
Free Cash Flow Analysis
Fennec Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Fennec Pharmaceuticals Inc
Revenue
|
30.9m
USD
|
Cost of Revenue
|
-3m
USD
|
Gross Profit
|
27.9m
USD
|
Operating Expenses
|
-39.9m
USD
|
Operating Income
|
-12m
USD
|
Other Expenses
|
-2.5m
USD
|
Net Income
|
-14.4m
USD
|
FRX Profitability Score
Profitability Due Diligence
Fennec Pharmaceuticals Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Fennec Pharmaceuticals Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
FRX Solvency Score
Solvency Due Diligence
Fennec Pharmaceuticals Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Fennec Pharmaceuticals Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FRX Price Targets Summary
Fennec Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for FRX is 17.71 CAD with a low forecast of 13.7 CAD and a high forecast of 21.36 CAD.
Dividends
Current shareholder yield for FENC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one FRX stock under the Base Case scenario is 25.26 CAD.
Compared to the current market price of 10.77 CAD, Fennec Pharmaceuticals Inc is Undervalued by 57%.